Search research articles
Contact Us
Filters
Showing results (171-180 of 211) with videos related to
Page
of 22
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 26, 1998
Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene
P A Kyrle, C Mannhalter, S Béguin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 22, 2017
Co-morbidities and bleeding in elderly patients with haemophilia-A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH)
W Miesbach, S-E Reitter-Pfoertner, R Klamroth, et al.
Thrombosis Research
|
November 5, 1997
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings
K Ruzicka, S Kapiotis, P Quehenberger, et al.
Annals of Hematology
|
April 1, 1996
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study
F Thalhammer, K Geissler, U Jäger, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden
I Pabinger, L Nemes, C Rintelen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 29, 2015
Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup> ) in adults with severe haemophilia A: efficacy and safety
T Lissitchkov, K Hampton, M von Depka, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 12, 2018
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients
L-M Mauracher, F Posch, K Martinod, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 24, 2012
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
J Thaler, C Ay, N Mackman, et al.
Leukemia
|
August 11, 1998
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis
A Weltermann, I Pabinger, K Geissler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2007
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria
H Pollmann, D Externest, A Ganser, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 211) with videos related to
Sort By:
Page
of 22
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 26, 1998
Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene
P A Kyrle, C Mannhalter, S Béguin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 22, 2017
Co-morbidities and bleeding in elderly patients with haemophilia-A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH)
W Miesbach, S-E Reitter-Pfoertner, R Klamroth, et al.
Thrombosis Research
|
November 5, 1997
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings
K Ruzicka, S Kapiotis, P Quehenberger, et al.
Annals of Hematology
|
April 1, 1996
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study
F Thalhammer, K Geissler, U Jäger, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden
I Pabinger, L Nemes, C Rintelen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 29, 2015
Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup> ) in adults with severe haemophilia A: efficacy and safety
T Lissitchkov, K Hampton, M von Depka, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 12, 2018
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients
L-M Mauracher, F Posch, K Martinod, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 24, 2012
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
J Thaler, C Ay, N Mackman, et al.
Leukemia
|
August 11, 1998
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis
A Weltermann, I Pabinger, K Geissler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2007
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria
H Pollmann, D Externest, A Ganser, et al.
Page
of 22